| Relative biological effectiveness in proton beam therapy–Current knowledge and future challenges A Lühr, C von Neubeck, M Krause, EGC Troost Clinical and translational radiation oncology 9, 35-41, 2018 | 141 | 2018 |
| LET-painting increases tumour control probability in hypoxic tumours N Bassler, J Toftegaard, A Lühr, BS Sørensen, E Scifoni, M Krämer, ... Acta Oncologica 53 (1), 25-32, 2014 | 138 | 2014 |
| Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets T Skripcak, C Belka, W Bosch, C Brink, T Brunner, V Budach, D Büttner, ... Radiotherapy and Oncology 113 (3), 303-309, 2014 | 122 | 2014 |
| Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis A Jakobi, A Bandurska-Luque, K Stützer, R Haase, S Löck, LJ Wack, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 1165-1174, 2015 | 114 | 2015 |
| “Radiobiology of Proton Therapy”: Results of an international expert workshop A Lühr, C von Neubeck, J Pawelke, A Seidlitz, C Peitzsch, SM Bentzen, ... Radiotherapy and Oncology 128 (1), 56-67, 2018 | 107 | 2018 |
| Predicting late magnetic resonance image changes in glioma patients after proton therapy J Eulitz, EGC Troost, F Raschke, E Schulz, B Lutz, A Dutz, S Löck, ... Acta Oncologica 58 (10), 1536-1539, 2019 | 78 | 2019 |
| The impact of modeling nuclear fragmentation on delivered dose and radiobiology in ion therapy A Lühr, DC Hansen, R Teiwes, N Sobolevsky, O Jäkel, N Bassler Physics in Medicine & Biology 57 (16), 5169, 2012 | 51 | 2012 |
| Optimizing SHIELD-HIT for carbon ion treatment DC Hansen, A Lühr, N Sobolevsky, N Bassler Physics in Medicine & Biology 57 (8), 2393, 2012 | 51 | 2012 |
| Stopping power for particle therapy: The generic library libdEdx and clinically relevant stopping-power ratios for light ions A Lühr, J Toftegaard, I Kantemiris, DC Hansen, N Bassler International Journal of Radiation Biology 88 (1-2), 209-212, 2012 | 50 | 2012 |
| Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? BS Sørensen, J Pawelke, J Bauer, NG Burnet, A Dasu, M Høyer, ... Radiotherapy and oncology 163, 177-184, 2021 | 49 | 2021 |
| NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy A Jakobi, K Stützer, A Bandurska-Luque, S Löck, R Haase, LJ Wack, ... Acta Oncologica 54 (9), 1658-1664, 2015 | 49 | 2015 |
| SHIELD-HIT12A-a Monte Carlo particle transport program for ion therapy research N Bassler, DC Hansen, A Lühr, B Thomsen, JB Petersen, N Sobolevsky Journal of Physics: Conference Series 489 (1), 012004, 2014 | 42 | 2014 |
| experimental verification of magnetic field‐induced beam deflection and Bragg peak displacement for MR‐integrated proton therapy SM Schellhammer, S Gantz, A Lühr, BM Oborn, M Bussmann, ... Medical Physics 45 (7), 3429-3434, 2018 | 39 | 2018 |
| Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours A Dutz, A Lühr, L Agolli, EGC Troost, M Krause, M Baumann, X Vermeren, ... Radiotherapy and Oncology 130, 164-171, 2019 | 36 | 2019 |
| Parameter-free one-center model potential for an effective one-electron description of molecular hydrogen A Lühr, YV Vanne, A Saenz Physical Review A 78 (4), 042510, 2008 | 36 | 2008 |
| Research facility for radiobiological studies at the university proton therapy dresden E Beyreuther, M Baumann, W Enghardt, S Helmbrecht, L Karsch, ... International Journal of Particle Therapy 5 (1), 172-182, 2018 | 35 | 2018 |
| A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy J Eulitz, B Lutz, P Wohlfahrt, A Dutz, W Enghardt, C Karpowitz, M Krause, ... Physics in Medicine & Biology 64 (22), 225020, 2019 | 32 | 2019 |
| Antiproton and proton collisions with the alkali-metal atoms Li, Na, and K A Lühr, A Saenz Physical Review A 77 (5), 052713, 2008 | 30 | 2008 |
| Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints A Lühr, C von Neubeck, S Helmbrecht, M Baumann, W Enghardt, ... Acta Oncologica 56 (11), 1392-1398, 2017 | 29 | 2017 |
| Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy A Lühr, DC Hansen, O Jäkel, N Sobolevsky, N Bassler Physics in Medicine & Biology 56 (8), 2515, 2011 | 29 | 2011 |
Mechthild KrauseProfessorin für Translationale Radioonkologie, Universitätsklinikum Dresden/ DKFZ HeidelbergVerified email at uniklinikum-dresden.de
